The Endocrine Society is proud of its many distinguished members who lead the global endocrine community by advancing scientific knowledge, providing exemplary care, teaching the next generation of endocrinologists, and improving human health worldwide. For more than 80 years, the Society has recognized the achievements of its members with the annual Laurate Awards. Established in...
Anna Gloyn Wins 2026 Transatlantic Alliance Award in Endocrinology
The Endocrine Society and The European Society of Endocrinology (ESE) are delighted to announce Anna Gloyn, DPhil, FMedSci, as the winner of the fifth annual Transatlantic Alliance Award. The Transatlantic Alliance Award, launched in 2022, recognizes an international leader who has made significant advancements in endocrine research on both sides of the Atlantic — in Europe and the United States. Gloyn has...Endocrine Society Honors Endocrinology Leaders with 2026 Laureate Awards
The Endocrine Society today announced it has chosen 12 leading endocrinologists as winners of its prestigious 2026 Laureate Awards, the top honors in the field. These professionals have achieved breakthroughs in scientific discoveries and clinical care benefiting people with hundreds of conditions, including diabetes, thyroid disorders, obesity, hormone-related cancers, growth problems, osteoporosis and infertility. Established...
Endocrine Society Guideline Calls for Increased Screening for Common High BP Culprit
Many primary aldosteronism cases remain undiagnosed and untreated Endocrine Society experts encouraged more widespread screening for a common hormonal cause of high blood pressure known as primary aldosteronism in a new Clinical Practice Guideline released today. “Primary Aldosteronism: An Endocrine Society Clinical Practice Guideline” was published online and is being presented at ENDO 2025, the...
Scientific Statement aims to expand our research to advance the understanding of the cause and progression of type 1 diabetes. A new Scientific Statement released today by the Endocrine Society highlights potential research directions related to the pathogenesis of type 1 diabetes that should help with the development of new and improved treatment options. ...
As experts dedicated to providing patients with compassionate, evidence-based care every day, we are disappointed in the United States v. Skrmetti decision, which increases the likelihood that other states will limit or eliminate families’ and patients’ ability to access medical care. As doctors, nurse practitioners, and nurses, we believe that every patient is different. Decisions...
AMA Passes Resolution Calling for Expanded Access to Anti-obesity Medications
Endocrine Society champions resolution passed by House of Delegates On June 10, the American Medical Association (AMA) House of Delegates passed the Endocrine Society’s resolution to improve access to anti-obesity medications. In the resolution, the AMA committed to advocating for reducing the burden of prior authorization, when healthcare providers must seek insurance plan approval before...
The Endocrine Society today endorsed the introduction of the bipartisan Treat and Reduce Obesity Act (TROA) in the Senate. The legislation will ensure that Medicare and Medicaid beneficiaries have access to effective anti-obesity medications. Medicare coverage of anti-obesity medications is currently prohibited under law. Access to these medications would benefit millions of Americans. More than...
